The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries.
The number of cases of dengue are growing rapidly during the past few years. Major regions of the world that are affected by dengue are Africa, the Americas, the Eastern Mediterranean, Southeast Asia and the Western Pacific. As per the numbers provided by WHO, the number of reported cases is continuously increasing.A rising prevalence of dengue virus has raised the demand for diagnostic kits, which is expected to drive the dengue testing market in the near future.
Presently, the diagnostic test kits that are available for testing dengue are less effective. Due to the unavailability of effective diagnostic tools and high price of existing test kits, a need has been created for cost effective test kits with high specificity and sensitivity. As a result, companies operating in the market are currently focusing on the development of cost-effective and reliable test methods for dengue testing. In addition, increasing research and development activities to develop highly specific and sensitive diagnostic kits is also expected to create new growth opportunities for the manufacturers of dengue test kits. The major focus of the manufacturers is to develop point-of-care tests, which are rapid, sensitive and easy to use. Presently, a large number of methods for the detection of dengue virus are still dependent on cell culture and mice inoculation and such type of methods are slow and costly. Hence, there is a strong need of developing rapid, easy to use and sensitive methods for detection of dengue.
The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Dengue Testing by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
The report forecast global Dengue Testing market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2027.
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.
First, this report covers the present status and the future prospects of the global Dengue Testing market for 2015-2027.
Key Companies
Abnova
Roche Molecular Systems
Abbott Laboratories
InBios International
NovaTec Immundiagnostica
Sub.PerkinElmer
Quest Diagnostics
Certest Biotec
OriGene Technologies
Thermo Fisher
At the same time, we classify Dengue Testing according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Market by Order Type
ELISA-Based Tests
RT-PCR Based Tests
Dengue IgG/IgM Rapid Test
Market by Application
Hospitals
Public Health Laboratory
Diagnostic Centers
Others
Market Segment as follows:
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Dengue Testing market for the forecast period 2021 - 2027?
• What are the driving forces in the Dengue Testing market for the forecast period 2021 - 2027?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Dengue Testing industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?
For any other requirements, please feel free to contact us and we will provide you customized report.